Literature DB >> 11009192

Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?

J A Molina1, M J Sáinz-Artiga, A Fraile, F J Jiménez-Jiménez, C Villanueva, M Ortí-Pareja, F Bermejo.   

Abstract

We describe 12 patients with Parkinson's disease and pathologic gambling. This association has apparently never been reported. The patients were selected from a Parkinson's disease unit of 250 patients. They met Diagnostic and Statistical Manual of Mental Disorders, 4th edition, criteria for pathologic gambling. All patients underwent a neurologic, psychiatric, and psychologic examination, specifically noting the presence or absence of psychopathology in the spectrum of impulse control disorder and the nature of the gambling. Ten patients started gambling after the onset of Parkinson's disease and treatment with levodopa. The pathologic behavior was exclusively present or was markedly increased in "on" periods in 11 patients. All patients had motor fluctuations at the time of the study. Slot machines were the preferred source of gambling for 10 patients, similar to the Spanish gambling population. That the gambling behavior appears more often in the "on" periods of motor fluctuations and that it begins after the onset of Parkinson's disease in most patients and worsens with levodopa therapy suggest that it could be related to the dopaminergic tone in patients with Parkinson's disease and motor fluctuations (that is, it could represent a behavioral manifestation of pharmacologic treatment).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11009192     DOI: 10.1002/1531-8257(200009)15:5<869::aid-mds1016>3.0.co;2-i

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  54 in total

1.  Pramipexole and compulsive masturbation.

Authors:  Randy A Sansone; Mark Ferlan
Journal:  Psychiatry (Edgmont)       Date:  2007-09

2.  Effects of acute pramipexole on male rats' preference for gambling-like rewards II.

Authors:  Patrick S Johnson; Gregory J Madden; Jeffrey S Stein
Journal:  Exp Clin Psychopharmacol       Date:  2012-01-30       Impact factor: 3.157

3.  Aberrant sexual behaviours in Parkinson's disease during dopaminergic treatment.

Authors:  Antonino Cannas; Paolo Solla; Gian Luca Floris; Giulia Serra; Paolo Tacconi; Maria Giovanna Marrosu
Journal:  J Neurol       Date:  2007-02-04       Impact factor: 4.849

4.  Long-term follow-up of impulse control disorders in Parkinson's disease.

Authors:  Eugenia Mamikonyan; Andrew D Siderowf; John E Duda; Marc N Potenza; Stacy Horn; Matthew B Stern; Daniel Weintraub
Journal:  Mov Disord       Date:  2008-01       Impact factor: 10.338

5.  Sleep and impulsivity in Parkinson's disease.

Authors:  Michael K Scullin; Ann B Sollinger; Julia Land; Cathy Wood-Siverio; Lavezza Zanders; Raven Lee; Alan Freeman; Felicia C Goldstein; Donald L Bliwise; Stewart A Factor
Journal:  Parkinsonism Relat Disord       Date:  2013-07-21       Impact factor: 4.891

6.  Dopaminergic Modulation of Decision Making and Subjective Well-Being.

Authors:  Robb B Rutledge; Nikolina Skandali; Peter Dayan; Raymond J Dolan
Journal:  J Neurosci       Date:  2015-07-08       Impact factor: 6.167

Review 7.  Antiparkinsonian medication and pathological gambling.

Authors:  Malcolm Lader
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 8.  Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Authors:  Sean S O'Sullivan; Andrew H Evans; Andrew J Lees
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

9.  Prevalence of problem and pathological gambling in Parkinson's disease.

Authors:  David Crockford; Jeremy Quickfall; Shawn Currie; Sarah Furtado; Oksana Suchowersky; Nady El-Guebaly
Journal:  J Gambl Stud       Date:  2008-06-17

10.  Dopaminergic drugs modulate learning rates and perseveration in Parkinson's patients in a dynamic foraging task.

Authors:  Robb B Rutledge; Stephanie C Lazzaro; Brian Lau; Catherine E Myers; Mark A Gluck; Paul W Glimcher
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.